Really good post Jr!... now interested in HZNP & ALXA. Still holding PATH, and probably should have bought the low at 2.38. Your post made me wonder 2 things (1) when would I actually sell PATH for a loss vs wait out the gain, (2) what is the best way to time, or is there a method, to better time these FDA approval ramp to production bio calender investments.
Re #1, imo this answer is dependent on #2, where I see (for PATH) the lack of any news as a positive, indicating buyout and/or partnering; I would be a buyer down to $2.01 on a clean reversal with no news, below I'd would probably take my lumps.
Re #2, I'm up for any suggestions. Believing in the fundamental story; for PATH I have confidence in their managers, their product and their patents. Similarly believe the story for NAVB. But like you point out believing can be a long slog.
Market Data 
Markets 
